Henry Schein, Inc. SEC filings document the formal disclosures of a Nasdaq-listed health care solutions company serving dental and medical practices and alternate care sites. The company’s 8-K filings report operating results, financial condition updates, press-release exhibits, leadership changes, board actions, and executive-compensation matters.
Proxy materials cover annual meeting matters, director and board-governance disclosures, and stockholder voting procedures. The filing record also identifies Henry Schein’s common stock, par value $0.01 per share, traded under HSIC on the Nasdaq Global Select Market, along with related corporate and Inline XBRL cover-page disclosures.
Henry Schein Inc. reported that CEO Frederick M. Lowery received new equity compensation awards. He was granted stock options for 177,116 shares with an exercise price of $77.60 per share, expiring in 2036, which vest in equal parts over four years, subject to continued service.
Lowery also received 64,433 shares of common stock as restricted stock units under the 2024 Stock Incentive Plan. Half of these are performance stock units that vest on the third anniversary based on achievement of specified goals, with payout ranging from 0% to 200%, and half are time-based RSUs vesting over four years. Following these grants, he directly owns 95,156 common shares in addition to the new option award.
Ettinger Michael S reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein, Inc. executive vice president and chief operating officer Michael S. Ettinger received a grant of 27,061 shares of common stock on March 6, 2026 as a compensation award. The grant was made at a price of $0.00 per share.
According to the company’s 2024 Stock Incentive Plan, half of this award consists of performance stock units that can pay out between 0% and 200% based on specified performance goals, vesting on the third anniversary of the grant date. The other half consists of time-based restricted stock units that vest in equal portions on each of the first four anniversaries, all subject to continued service.
Following this award, Ettinger directly holds 118,722 shares of Henry Schein common stock. He also has an indirect interest equivalent to 210 shares through the Henry Schein 401(k) Savings Plan’s unitized stock fund.
Albertini Andrea reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. executive Andrea Albertini, CEO, Global Distribution & Technology, received a grant of 60,631 shares of common stock as equity compensation. Following this award, he directly holds 122,092 shares.
The grant consists of restricted stock units under the 2024 Stock Incentive Plan. Half of the grant is performance-based and will vest on the third anniversary of the grant date if specified performance goals are met, with payout for these performance stock units scaling from 0% to a maximum of 200%. The remaining half will vest in equal installments on each of the first four anniversaries of the grant date, in each case subject to continued service.
Henry Schein Inc. director Reed Vaughn Tuckson reported an equity award from the company. On March 6, 2026, he acquired 2,577 shares of common stock at a stated price of $0.00 per share, described as a grant, award, or other acquisition.
The award was granted under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan. According to the footnote, the restricted stock units generally vest after a 12‑month cliff period, subject to certain exceptions and to his continued service to the company. Following this grant, he directly owned 12,520 shares of common stock.
SHEARES BRADLEY T reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Bradley T. Sheares received an equity award of 2,577 shares of common stock on March 6, 2026. The grant was made at no cash cost to him under the company’s 2023 Non-Employee Director Stock Incentive Plan.
According to the terms, these restricted stock units vest after a 12-month cliff period, contingent on his continued service to Henry Schein. Following this award, he beneficially owns 47,623 shares of the company’s common stock directly.
Henry Schein Inc. director Scott Philip Serota reported an equity award in the company’s common stock. He acquired 2,577 shares on a grant or award basis at $0.00 per share, bringing his directly held stake to 10,790 shares.
The award was granted under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan. According to the terms, these restricted stock units generally vest after a 12‑month cliff period, conditioned on the passage of time and his continued service to the company.
Separately, an additional 1,000 shares are reported as held indirectly by the Serota Family Trust, for which Mr. Serota and his wife serve as both trustees and beneficiaries.
Margulies Anne H. reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Anne H. Margulies reported an equity award of 2,577 shares of common stock on March 6, 2026. The award was granted at no cash cost to her as a stock-based grant.
The grant was made under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan as restricted stock units that vest after a 12‑month cliff period, subject to her continued board service. Following this award, her directly held common stock totaled 23,153 shares.
Henry Schein Inc. director Philip A. Laskawy reported an equity award from the company. On March 6, 2026, he acquired 2,577 shares of common stock in the form of restricted stock units at a stated price of $0.00 per share.
The award was granted under Henry Schein’s 2023 Non-Employee Director Stock Incentive Plan. These restricted stock units are scheduled to vest after a 12‑month cliff period, subject to limited exceptions and his continued service to the company. Following this grant, he holds 24,538 shares directly.
Henry Schein Inc. director Kurt P. Kuehn reported an equity award. On March 6, 2026, he acquired 2,577 shares of common stock at a stated price of $0.00 per share through a grant under the company’s 2023 Non-Employee Director Stock Incentive Plan.
According to the award terms, these restricted stock units are subject to 12‑month cliff vesting and require his continued service with Henry Schein during that period. Following this grant, Kuehn’s directly held position increased to 18,264 shares of common stock.